Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Parkinsonism: onset, progression, and mortality

Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107 · see citing works

Unified Parkinson's Disease Rating Scale

(2012) · Springer eBooks · doi:10.1007/springerreference_184495 · Cited by 3,071 · see citing works

Recent developments in Parkinson's disease

Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,165 · see citing works

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757 · see citing works

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397 · see citing works

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · see citing works

Abnormalities of the electron transport chain in idiopathic parkinson's disease

Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061 · see citing works

Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline

Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · see citing works

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.

Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981 · see citing works

Oxidative stress and the pathogenesis of Parkinson's disease

Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971 · see citing works

CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL

Scoppetta, C., & Vaccario, M. L. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 755 · see citing works

Parkinson's disease: A disorder due to nigral glutathione deficiency?

Perry, T. L., Godin, D. V., & Hansen, S. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90390-1 · Cited by 753 · see citing works

Criteria for diagnosing Parkinson's disease

Calne, D. B., Snow, B. J., & Lee, C. (1992) · Annals of Neurology · doi:10.1002/ana.410320721 · Cited by 628 · see citing works

Coenzyme Q ₁₀ administration increases brain mitochondrial concentrations and exerts neuroprotective effects

Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557 · see citing works

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

Sofic, E., Paulus, W., Jellinger, K. A., Riederer, P. F., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 523 · see citing works

A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra

Saggu, H. K., Cooksey, J., Dexter, D. T., Wells, F. R., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454 · see citing works

Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study

Dexter, D. T., Holley, A. E., Flitter, W. D., Slater, T. F., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1994) · Movement Disorders · doi:10.1002/mds.870090115 · Cited by 407 · see citing works

Platelet mitochondria function in Parkinson's disease

Krige, D., Carroll, M. T., Cooper, J. A. D., MARSDEN, C. D., & Schapira, A. H. V. (1992) · Annals of Neurology · doi:10.1002/ana.410320612 · Cited by 358 · see citing works

Mitochondrial oxidative phosphorylation defects in parkinson's disease

Shoffner, J. M., Watts, R. L., Juncos, J. L., Torroni, A., & Wallace, D. C. (1991) · Annals of Neurology · doi:10.1002/ana.410300304 · Cited by 333 · see citing works

Coenzyme Q₁₀ levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects

Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326 · see citing works

Systemic Increase of Oxidative Nucleic Acid Damage in Parkinson's Disease and Multiple System Atrophy

Kikuchi, A., Takeda, A., Onodera, H., Kimpara, T., Hisanaga, K., Sato, N., Nunomura, A., Castellani, R. J., Perry, G. L., Smith, M. A., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0466 · Cited by 289 · see citing works

Oxygen toxicity protecting enzymes in Parkinson's disease

Marttila, R. J., Lorentz, H., & Rinne, U. K. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90108-6 · Cited by 249 · see citing works

MITOCHONDRIAL FUNCTION IN PARKINSON'S DISEASE

Bindoff, L. A., Birch‐Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90291-2 · Cited by 245 · see citing works

Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease

Foy, C. J. (1999) · QJM · doi:10.1093/qjmed/92.1.39 · Cited by 235 · see citing works

Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease

Bindoff, L. A., Birch‐Machin, M. A., Cartlidge, N. E. F., Parker, W. D., & Turnbull, D. M. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90311-t · Cited by 229 · see citing works

Simultaneous Detection of Ubiquinol and Ubiquinone in Human Plasma as a Marker of Oxidative Stress

Yamashita, S., & Yamamoto, Y. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2187 · Cited by 220 · see citing works

Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes

Benecke, R., Strumper, P., & Weiss, H. (1993) · Brain · doi:10.1093/brain/116.6.1451 · Cited by 220 · see citing works

Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy

Blin, O. J., Desnuelle, C., Rascol, O., Borg, M., Paul, H. P. S., Azulay, J., Billé, F., Figarella-Branger, D. F., Coulom, F., Pellissier, J., et al. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90248-8 · Cited by 182 · see citing works

Oxidative Stress in Patients with Hepatitis, Cirrhosis, and Hepatoma Evaluated by Plasma Antioxidants

Yamamoto, Y., Yamashita, S., Fujisawa, A., Kokura, S., & Yoshikawa, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8752 · Cited by 147 · see citing works

Mitochondria1 respiratory chain activity in skeletal muscle from patients with Parkinson's disease

Cardellach, F., Martí, M. J., Fernández‐Solà, J., Marín, C., Hoek, J. B., TOLOSA, E. S., & Urbano-Márquez, A. (1993) · Neurology · doi:10.1212/wnl.43.11.2258 · Cited by 131 · see citing works

Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q 10 in parkinsonian patients

Shults, C. W., Beal, M. F., Fontaine, D., Nakano, K., & Haas, R. (1998) · Neurology · doi:10.1212/wnl.50.3.793 · Cited by 116 · see citing works

Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients

DiDonato, S., Zeviani, M., Giovannini, P., Savarese, N., Rimoldi, M., Mariotti, C., Girotti, F., & CARACENI, T. (1993) · Neurology · doi:10.1212/wnl.43.11.2262 · Cited by 98 · see citing works

Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease

Abe, T., Isobe, C., Murata, T., Sato, C., & Tohgi, H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01259-4 · Cited by 97 · see citing works

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

Ahlskog, J. E., Uitti, R. J., Low, P. A., Tyce, G. M., Nickander, K. K., Petersen, R. C., & Kokmen, E. (1995) · Movement Disorders · doi:10.1002/mds.870100507 · Cited by 90 · see citing works

Detection of lipid hydroperoxides and hydrogen peroxide at picamole levels by an HPLC and isoluminol chemiluminescence assay

Yamamoto, Y., & Ames, B. N. (1987) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(87)80048-5 · Cited by 83 · see citing works

Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease

Barroso, N., Campos, Y., Huertas, R., Esteban, J., Molina, J. A., Alonso, A., Gutiérrez‐Rivas, E., & Arenas, J. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.667 · Cited by 80 · see citing works

Oxidative damage and repair (63-73)

(1999) · Journal of Radiation Research · doi:10.1269/jrr.40.392 · Cited by 80 · see citing works

Oxidative Stress in Newborn Infants with and without Asphyxia as Measured by Plasma Antioxidants and Free Fatty Acids

Hara, K., Yamashita, S., Fujisawa, A., Ishiwa, S., Ogawa, T., & Yamamoto, Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0436 · Cited by 76 · see citing works

Is Parkinson's disease a mitochondrial disorder?

Nakagawa-Hattori, Y., Yoshino, H., Kondo, T., Mizuno, Y., & Horai, S. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90205-y · Cited by 71 · see citing works

Serum levels of alpha‐tocopherol (vitamin E) in Parkinson's disease

Fernández–Calle, P., Molina, J. A., Jiménez-Jiménez, F. J., Vázquez, A., Pondal, M., Ruiz, P., Urra, D. G., Domingo, J. V., & Codoceo, R. (1992) · Neurology · doi:10.1212/wnl.42.5.1064 · Cited by 51 · see citing works

Serum levels of coenzyme Q10 in patients with Parkinson's disease

Jiménez‐Jiménez, F. J., Molina, J. A., de Bustos, F., García‐Redondo, A., Gómez-Escalonilla, C., Martínez‐Salio, A., Berbel, Á., Camacho, A., Zurdo, M., Barcenilla, B., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050015 · Cited by 50 · see citing works

Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis, and hepatoma, and in patients treated with percutaneous transluminal coronary reperfusion

Yamamoto, Y., & Yamashita, S. (1999) · BioFactors · doi:10.1002/biof.5520090219 · Cited by 46 · see citing works

Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease

Bravi, D., Anderson, J. J., Dagani, F., Davis, T. L., Ferrari, R., Gillespie, M., & Chase, T. N. (1992) · Movement Disorders · doi:10.1002/mds.870070307 · Cited by 43 · see citing works

Respiratory‐chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients

Martín, M. A., Molina, J. A., Jiménez-Jiménez, F. J., Benito‐León, J., Pareja, M. O., Campos, Y., Arenas, J., & del Movimiento, T. G. C. D. T. (1996) · Neurology · doi:10.1212/wnl.46.5.1343 · Cited by 39 · see citing works

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease

Molina, J. A., de Bustos, F., Jiménez‐Jiménez, F. J., Benito‐León, J., Pareja, M. O., Gasallo, T., Tallón-Barranco, A., Navarro, J. A., Arenas, J., & Enríquez-de-Salamanca, R. (1997) · Journal of Neural Transmission · doi:10.1007/bf01294729 · Cited by 35 · see citing works

Serum levels of β-carotene and other carotenoids in Parkinson's disease

Jiménez‐Jiménez, F. J., Molina, J., Fernández–Calle, P., Vázquez, A., Cabrera‐Valdivia, F., Catalán, M. J., García-Albea, E., Bermejo, F., & Codoceo, R. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90653-3 · Cited by 33 · see citing works

FORMATION OF LIPID HYDROPEROXIDES IN THE CUPRIC ION-INDUCED OXIDATION OF PLASMA AND LOW DENSITY LIPOPROTEIN

Yamamoto, Y., Kawamura, M., Tatsuno, K., Yamashita, S., Niki, E., & NAITO, C. (1991) · Elsevier eBooks · doi:10.1016/b978-0-08-041749-3.50055-3 · Cited by 30 · see citing works

Normal cerebrospinal fluid glutathione concentrations in Parkinson’s disease, Alzheimer’s disease and multiple system atrophy

Konings, C. H., Kuiper, M. A., Teerlink, T., Mulder, C., Scheltens, P., & Wolters, E. C. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00167-7 · Cited by 28 · see citing works

Respiratory chain enzyme activities in spermatozoa from untreated Parkinson's disease patients

Molina, J. A., Ruiz‐Pesini, E., Jim�nez-Jim�nez, F. J., L�pez-P�rez, M. J., Alvarez, E., Berbel, Á., Pareja, M. O., Zurdo, M., de Bustos, F., Arenas, J., et al. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050211 · Cited by 3 · see citing works

Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging

Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works

Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases

Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Rahman, H. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,182 · see citing works

Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism

Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677 · see citing works

Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics

Duan, Y., Gong, K., Xu, S., Zhang, F., Meng, X., & Han, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01125-5 · Cited by 538 · see citing works

Oxidative Stress in Parkinson's Disease

Zhou, C. H., Huang, Y., & Przedborski, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.023 · Cited by 453 · see citing works

The pathogenesis of cell death in Parkinson's disease

Jenner, P. G., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 449 · see citing works

The Role of Oxidative Stress in Parkinson’s Disease

Chang, K., & Chen, C. (2020) · Antioxidants · doi:10.3390/antiox9070597 · Cited by 357 · see citing works

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245 · see citing works

Total cholesterol and the risk of Parkinson disease

Hu, G., Antikaínen, R., Jousilahti, P., Kivipelto, M., & Tuomilehto, J. (2008) · Neurology · doi:10.1212/01.wnl.0000312511.62699.a8 · Cited by 205 · see citing works

Serum Cholesterol Levels and the Risk of Parkinson's Disease

de Lau, L. M. L., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj283 · Cited by 205 · see citing works

Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

Dai, L., Zou, L. B., Meng, L., Qiang, G., Yan, M., & Zhang, Z. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02232-6 · Cited by 195 · see citing works

Coenzyme Q10 effects in neurodegenerative disease

Henchcliffe, C. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5212 · Cited by 188 · see citing works

Clinical applications of coenzyme Q₁₀

Garrido-Maraver, J. (2014) · Frontiers in Bioscience · doi:10.2741/4231 · Cited by 178 · see citing works

Recent Advances in Biomarkers for Parkinson’s Disease

He, R., Yan, X., Guo, J., Xu, Q., Tang, B., & Sun, Q. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00305 · Cited by 178 · see citing works

Therapeutic effects of coenzyme Q 10 (CoQ 10 ) and reduced CoQ 10 in the MPTP model of Parkinsonism

Cléren, C., Yang, L., Lorenzo, B. J., Calingasan, N. Y., Schomer, A. C., Sireci, A. N., Wille, E. J., & Beal, M. F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05097.x · Cited by 158 · see citing works

Coenzyme Q10 Therapy

Garrido‐Maraver, J., Cordero, M. D., Oropesa-Ávila, M., Fernández-Vega, A., de la Mata, M., Pavón, A. D., de Miguel, M., Calero, C. P., Paz, M. V., Cotán, D., et al. (2014) · Molecular Syndromology · doi:10.1159/000360101 · Cited by 154 · see citing works

Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease

Faust, K., Gehrke, S., Yang, Y., Yang, L., Beal, M. F., & Lu, B. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-109 · Cited by 151 · see citing works

Coenzyme Q10 and Heart Failure

Sharma, A., Fonarow, G. C., Butler, J., Ezekowitz, J. A., & Felker, G. M. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002639 · Cited by 150 · see citing works

Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan

Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.002 · Cited by 141 · see citing works

Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders

Covarrubias‐Pinto, A., Acuña, A. I., Beltrán, F. A., Torres-Díaz, L., & Castro, M. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226095 · Cited by 140 · see citing works

The Promise of Neuroprotective Agents in Parkinson?s Disease

Seidl, S. E., & Potashkin, J. A. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00068 · Cited by 141 · see citing works

Therapeutic use of coenzyme Q 10 and coenzyme Q 10 -related compounds and formulations

Villalba, J. M., Parrado‐Fernández, C., González, M. S., & Alcain, F. J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003727495 · Cited by 134 · see citing works

Targeting mitophagy in Parkinson's disease

Clark, E. H., de la Torre, A. V., Hoshikawa, T., & Briston, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.014294 · Cited by 128 · see citing works

Post-Stroke Cognitive Impairment: A Review Focusing on Molecular Biomarkers

Zhang, X., & Bi, X. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01533-8 · Cited by 128 · see citing works

Coenzyme Q10 deficiency in patients with Parkinson's disease

Mischley, L. K., Allen, J., & Bradley, R. D. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.03.023 · Cited by 111 · see citing works

Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease

Yoritaka, A., Kawajiri, S., Yamamoto, Y., Nakahara, T., Ando, M., Hashimoto, K., Nagase, M., Saito, Y., & Hattori, N. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.05.022 · Cited by 94 · see citing works

Peripheral markers in neurodegenerative patients and their first-degree relatives

Cristalli, D. O., Arnal, N., Marra, F. A., de Alaniz, M. J. T., & Marra, C. A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.11.001 · Cited by 92 · see citing works

Clinical aspects of coenzyme Q10: an update

Littarru, G. P., & Tiano, L. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000171123.60665.16 · Cited by 92 · see citing works

Coenzyme Q10: is there a clinical role and a case for measurement?

Molyneux, S. L., Young, J. M., Florkowski, C. M., Lever, M., & George, P. M. (2008) · PubMed Central · Cited by 87 · see citing works

Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?

Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 86 · see citing works

Antioxidants, Supplements, and Parkinson's Disease

Weber, C. A., & Ernst, M. E. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g551 · Cited by 85 · see citing works

LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases

Xu, P., Li, D.-B., Tang, X., Bao, X., Huang, J., Tang, Y.-P., Yang, Y., Xu, H., & Fan, X.-T. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8461-3 · Cited by 84 · see citing works

Antioxidant Therapeutics in Parkinson’s Disease: Current Challenges and Opportunities

Duarte-Jurado, A. P., Gopar‐Cuevas, Y., Cárdenas, O. S., Loera‐Arias, M. D. J., Montes‐de‐Oca‐Luna, R., García‐García, A., & Rodríguez‐Rocha, H. (2021) · Antioxidants · doi:10.3390/antiox10030453 · Cited by 82 · see citing works

Oxidative stress and Parkinson's disease

Jenner, P. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83024-7 · Cited by 79 · see citing works

Coenzyme Q treatment of neurodegenerative diseases of aging

Galpern, W. R., & Cudkowicz, M. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.01.004 · Cited by 78 · see citing works

Therapeutic role of coenzyme Q10 in Parkinson's disease

Shults, C. W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.002 · Cited by 76 · see citing works

Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development

Nierenberg, A. A., Kansky, C., Brennan, B. P., Shelton, R. C., Perlis, R. H., & Iosifescu, D. V. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449303 · Cited by 76 · see citing works

Oxidative Stress: Mechanistic Insights into Inherited Mitochondrial Disorders and Parkinson’s Disease

Shahrani, M. M. A., Heales, S., Hargreaves, I. P., & Orford, M. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6110100 · Cited by 78 · see citing works

Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the l-dopa

Agil, A., Durán, R., Barrero, F. J., Morales, B., Arauzo, M., Alba, F., León, M. T. M., Prieto, I., Ramírez, M. R., & Vives, F. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.016 · Cited by 71 · see citing works

α-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy

Alleva, R., Nasole, E., Donato, F. D., Borghi, B., Neužil, J., & Tomasetti, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.119 · Cited by 71 · see citing works

An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients

Sohmiya, M., Tanaka, M., Suzuki, Y., Tanino, Y., Okamoto, K., & Yamamoto, Y. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.030 · Cited by 69 · see citing works

Analysis of coenzyme Q in human blood and tissues

Barshop, B. A., & Gangoiti, J. A. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.04.002 · Cited by 63 · see citing works

Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson’s Disease by Oral Administration of Ether Phospholipids: A Preliminary Report

Mawatari, S., Ohara, S., Taniwaki, Y., Tsuboi, Y., Maruyama, T., & Fujino, T. (2020) · Parkinson s Disease · doi:10.1155/2020/2671070 · Cited by 58 · see citing works

Association of serum carotenoid, retinol, and tocopherol concentrations with the progression of Parkinson's Disease

Kim, J. H., Hwang, J., Shim, E., Chung, E.-J., Jang, S. H., & Koh, S. (2017) · Nutrition Research and Practice · doi:10.4162/nrp.2017.11.2.114 · Cited by 58 · see citing works

Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement

Lorenzo, A. D., Iannuzzo, G., Parlato, A., Cuomo, G., Testa, C., Coppola, M., D’Ambrosio, G., Oliviero, D. A., Sarullo, S., Vitale, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051266 · Cited by 59 · see citing works

Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease

Dragonas, C., Bertsch, T., Sieber, C. C., & Brosche, T. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.205 · Cited by 57 · see citing works

Quantitative Proteomics of a Presymptomatic A53T α-Synuclein Drosophila Model of Parkinson Disease

Xun, Z., Sowell, R. A., Kaufman, T. C., & Clemmer, D. E. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700467-mcp200 · Cited by 57 · see citing works

Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentration

Niklowitz, P., Onur, S., Fischer, A., Laudes, M., Palussen, M., Menke, T., & Döring, F. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-73 · Cited by 55 · see citing works

Lipophilic antioxidants in neurodegenerative diseases

Chang, K., Cheng, M., Chiang, M.-C., & Chen, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.06.031 · Cited by 55 · see citing works

Coenzyme Q10 (Ubiquinol-10) Supplementation Improves Oxidative Imbalance in Children With Trisomy 21

Miles, M. V., Patterson, B. J., Chalfonte-Evans, M., Horn, P. S., Hickey, F. J., Schapiro, M. B., Steele, P. E., Tang, P., & Hotze, S. L. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.08.003 · Cited by 52 · see citing works

Role of Serum Cholesterol in Parkinson's Disease: A Meta-Analysis of Evidence

Gudala, K., Bansal, D., & Muthyala, H. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130196 · Cited by 50 · see citing works

Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T Polymorphism in Levodopa-treated Parkinson’s Disease Patients

Gorgone, G., Currò, M., Ferlazzo, N., Parisi, G., Parnetti, L., Belcastro, V., Tambasco, N., Rossi, A., Pisani, F., Calabresi, P., et al. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8174-1 · Cited by 48 · see citing works

Management of the aging risk factor for Parkinson's disease

Phillipson, O. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.073 · Cited by 46 · see citing works

Dysregulation of stress systems and nitric oxide signaling underlies neuronal dysfunction in Alzheimer’s disease

Spiers, J. G., Chen, H. C., Bourgognon, J.-M., & Steinert, J. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.025 · Cited by 45 · see citing works

Physical activity affects plasma coenzyme Q10 levels differently in young and old humans

del Pozo-Cruz, J., Rodríguez-Bies, E., Ballesteros‐Simarro, M., Navas‐Enamorado, I., Tùng, B. T., Navas, P., & López‐Lluch, G. (2014) · Biogerontology · doi:10.1007/s10522-013-9491-y · Cited by 44 · see citing works

REDOX STATUS OF COENZYME Q 10 IS ASSOCIATED WITH CHRONOLOGICAL AGE

Wada, H., Goto, H., Hagiwara, S.-I., & Yamamoto, Y. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01209.x · Cited by 44 · see citing works

Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?

Brembati, V., Faustini, G., Longhena, F., & Bellucci, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1197853 · Cited by 42 · see citing works

Biomarkers of Parkinson's disease and Dementia with Lewy bodies

Henchcliffe, C., Dodel, R. C., & Beal, M. F. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.002 · Cited by 42 · see citing works

Carotenoids: Role in Neurodegenerative Diseases Remediation

Gandla, K., Babu, A. K., Unnisa, A., Sharma, I., Singh, L. P., Haque, M. A., Dashputre, N. L., Baig, S., Siddiqui, F. A., Khandaker, M. U., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13030457 · Cited by 41 · see citing works

Improvement of the oral bioavailability of coenzyme Q10 by emulsification with fats and emulsifiers used in the food industry

Thanatuksorn, P., Kawai, K., Hayakawa, M., Hayashi, M. K., & Kajiwara, K. (2008) · LWT · doi:10.1016/j.lwt.2008.03.006 · Cited by 40 · see citing works

High-accuracy analysis system for the redox status of coenzyme Q10 by online supercritical fluid extraction–supercritical fluid chromatography/mass spectrometry

Matsubara, A., Harada, K., Hirata, K., Fukusaki, E., & Bamba, T. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.05.009 · Cited by 39 · see citing works

Total Cholesterol and the Risk of Parkinson's Disease: A Review for Some New Findings

Hu, G. (2009) · Parkinson s Disease · doi:10.4061/2010/836962 · Cited by 37 · see citing works

Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?

Leathem, A., Ortíz, T., Dennis, J. M., & Witting, P. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136923 · Cited by 36 · see citing works

Acute restraint stress induces rapid and prolonged changes in erythrocyte and hippocampal redox status

Spiers, J. G., Chen, H. C., Bradley, A. J., Anderson, S. T., Sernia, C., & Lavidis, N. A. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.05.011 · Cited by 34 · see citing works

The potential role of cholesterol in Parkinson’s disease neuropathology: perpetrator or victim

Alrouji, M., Al-Kuraishy, H. M., Al-Mahammadawy, A.-K. A. A., Al-Gareeb, A. I., Saad, ‏. M., & Batiha, G. E. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06926-2 · Cited by 32 · see citing works

Increased oxidative stress and renal injury in patients with sepsis

Yamaguchi, J., Nagase, M., Yamamoto, Y., Sakurai, A., Kubo, A., Mitsuhashi, H., Matsuoka, M., Ihara, S., & Kinoshita, K. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-130 · Cited by 31 · see citing works

Qi-activating quercetin alleviates mitochondrial dysfunction and neuroinflammation in vivo and in vitro

Kang, S., Piao, Y., Kang, Y. C., Lim, S., & Pak, Y. K. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01238-x · Cited by 31 · see citing works

Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) as measured by redox status of plasma coenzyme Q10

Wada, H., Hagiwara, S.-I., Saitoh, E., Ieki, R., Okamura, T., Ota, T., Iguchi, M., Yuasa, K., Kodaka, T., Koishi, T., et al. (2005) · Pathophysiology · doi:10.1016/j.pathophys.2005.09.014 · Cited by 31 · see citing works

Iron Dysregulation and Inflammagens Related to Oral and Gut Health Are Central to the Development of Parkinson’s Disease

van Vuuren, M. J., Nell, T. A., Carr, J. A., Kell, D. B., & Pretorius, E. (2020) · Biomolecules · doi:10.3390/biom11010030 · Cited by 31 · see citing works

Blood-Based Protein Biomarkers for Diagnosis and Classification of Neurodegenerative Diseases

Noelker, C., Hampel, H. J., & Dodel, R. C. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256398 · Cited by 29 · see citing works

Therapeutic Efficacy of Plasmalogens for Alzheimer’s Disease, Mild Cognitive Impairment, and Parkinson’s Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer’s Disease

Fujino, T., Hossain, M. S., & Mawatari, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-60204-8_14 · Cited by 29 · see citing works

Analysis of coenzyme Q10 in bee pollen using online cleanup by accelerated solvent extraction and high performance liquid chromatography

Xue, X., Zhao, J., Chen, L., Zhou, J., Yue, B., Li, Y., Wu, L., & Liu, F. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2011.12.085 · Cited by 28 · see citing works

Coenzyme Q10 and its effects in the treatment of neurodegenerative diseases

dos Santos, G. C., Antunes, L. M. G., dos Santos, A. C., & Bianchi, M. D. L. P. (2009) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502009000400002 · Cited by 27 · see citing works

Association Between Serum Zinc Levels and the Risk of Parkinson’s Disease: a Meta-Analysis

Sun, H., Liu, X., Ge, H., Wang, T., Wang, Y., & Li, W. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-0941-2 · Cited by 27 · see citing works

A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium

Khan, M., Gross, J., Haupt, H., Jainz, A., Niklowitz, P., Scherer, H. H., Schmidt, F., Klapp, B. F., Reißhauer, A., & Mazurek, B. (2007) · Otolaryngology · doi:10.1016/j.otohns.2006.07.010 · Cited by 27 · see citing works

Coenzyme Q10 redox balance and a free radical scavenger drug

Yamamoto, Y. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.026 · Cited by 26 · see citing works

Determination of coenzyme Q10 tissue status via high-performance liquid chromatography with electrochemical detection in swine tissues (Sus scrofa domestica)

Niklowitz, P., Döring, F., Paulussen, M., & Menke, T. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.02.015 · Cited by 25 · see citing works

Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein

Li, G., Zou, L., Jack, C. R., Yang, Y., & Yang, E. S. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.005 · Cited by 25 · see citing works

Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review

Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060975 · Cited by 24 · see citing works

Impact of Genetic Variants of Apolipoprotein E on Lipid Profile in Patients with Parkinson's Disease

Gregório, M. L., Pinhel, M. A. S., Sado, C. L., Longo, G., Oliveira, F. N., Amorim, G. S., Nakazone, M. A., Florim, G. M. D. S., Mazeti, C. M., Martins, D. P., et al. (2013) · BioMed Research International · doi:10.1155/2013/641515 · Cited by 24 · see citing works

Plasma interleukin‐18 (IL‐18) levels are correlated with antioxidant vitamin coenzyme Q10 in preeclampsia

Roland, L., Gagné, A., Bélanger, M., Boutet, M., Julien, P., & Bilodeau, J. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016340903576020 · Cited by 24 · see citing works

Biomarkers for trials of neuroprotection in Parkinson's disease

Agarwal, P. A., & Stoessl, A. J. (2012) · Movement Disorders · doi:10.1002/mds.25065 · Cited by 22 · see citing works

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease

Blagov, A. V., Postnov, A. Y., Sukhorukov, V. N., Popov, M. A., Uzokov, J., & Orekhov, A. N. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901036 · Cited by 26 · see citing works

Protective Efficacy of Coenzyme Q10 Against DDVP-Induced Cognitive Impairments and Neurodegeneration in Rats

Binukumar, B. K., Gupta, N., Sunkaria, A., Kandimalla, R. J. L., Wani, W. Y., Sharma, D. R., Bal, A., & Gill, K. D. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9289-0 · Cited by 22 · see citing works

Determination of coenzyme Q10 in human seminal plasma by high‐performance liquid chromatography and its clinical application

Li, K., Shi, Y., Chen, S., Li, W., Shang, X., & Huang, Y. (2006) · Biomedical Chromatography · doi:10.1002/bmc.645 · Cited by 22 · see citing works

Validation and application of an HPLC‐EC method for analysis of coenzyme Q10 in blood platelets

Miles, M. V., Tang, P., Miles, L., Steele, P. E., Moye, M. J., & Horn, P. S. (2008) · Biomedical Chromatography · doi:10.1002/bmc.1072 · Cited by 20 · see citing works

LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration

Zhang, S., Xie, J., Xia, Y., Yu, S., Gu, Z.-L., Feng, R., Luo, G., Wang, D., Wang, K., Jiang, M., et al. (2015) · Scientific Reports · doi:10.1038/srep12564 · Cited by 20 · see citing works

Stable Isotope Labeling and Label-Free Proteomics of Drosophila parkin Null Mutants

Xun, Z., Kaufman, T. C., & Clemmer, D. E. (2009) · Journal of Proteome Research · doi:10.1021/pr9006238 · Cited by 19 · see citing works

Determination of Reduced and Oxidized Coenzyme Q10 in Canine Plasma and Heart Tissue by HPLC-ECD: Comparison with LC-MS/MS Quantification

Schou‐Pedersen, A. M. V., Schemeth, D., & Lykkesfeldt, J. (2019) · Antioxidants · doi:10.3390/antiox8080253 · Cited by 17 · see citing works

The role of biomarkers and imaging in Parkinson’s disease

Algarni, M., & Stoessl, A. J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1135056 · Cited by 17 · see citing works

Decreased Coenzyme Q10 Concentration in Plasma of Children with Cystic Fibrosis

Oudshoorn, J. H., Lecluse, A. L. Y., van den Berg, R., Vaes, W. H. J., van der Laag, J., & Houwen, R. H. J. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000233193.77521.66 · Cited by 16 · see citing works

Oxidative Stress in Parkinson's Disease

Vaya, J., Aluf, Y., & Finberg, J. P. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_12 · Cited by 16 · see citing works

Altered redox status of coenzyme Q9 reflects mitochondrial electron transport chain deficiencies in Caenorhabditis elegans

Vasta, V., Sedensky, M. M., Morgan, P. G., & Hahn, S. H. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.09.002 · Cited by 15 · see citing works

Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran.

Saedi, S., Hemmati-Dinarvand, M., Barmaki, H., Mokhtari, Z., Musavi, H., Valilo, M., Mota, A., & Mahjoub, S. (2021) · PubMed Central · doi:10.22088/cjim.12.2.155 · Cited by 14 · see citing works

Effects of various concentrations of inhaled oxygen on tissue dysoxia, oxidative stress, and survival in a rat hemorrhagic shock model

Takasu, A., Iwamoto, S., Ando, S., Minagawa, Y., Kashiba, M., Yamamoto, Y., & Sakamoto, T. (2009) · Resuscitation · doi:10.1016/j.resuscitation.2009.03.018 · Cited by 14 · see citing works

Coenzyme Q10 as a Front-Line Antioxidant against Oxidative Stress

Yamamoto, Y. (2005) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.36.29 · Cited by 13 · see citing works

Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors

Ding, Y., Tang, F., Xue, X., Luo, J., Hussain, M., Huang, Y., Wang, Z., Jiang, H., Tu, Z., & Zhang, J. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.03.044 · Cited by 12 · see citing works

Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease

Ghanta, M. K., Elango, P., & Bhaskar, L. V. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200217114658 · Cited by 11 · see citing works

Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinsons Disease?

Kirches, E. (2009) · Current Genomics · doi:10.2174/138920209789503879 · Cited by 11 · see citing works

Blood and cerebrospinal fluid markers in Parkinson's disease: current biomarker findings

Henchcliffe, C. (2014) · Current Biomarker Findings · doi:10.2147/cbf.s50424 · Cited by 11 · see citing works

Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson’s disease

Isobe, C., Murata, T., Sato, C., & Terayama, Y. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.12.023 · Cited by 22 · see citing works

Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review

Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060975 · Cited by 24 · see citing works

The coenzyme Q10 status of the brain regions of Parkinson’s disease patients

Hargreaves, I. P., Lane, A., & Abou‐Sleiman, P. M. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.069 · Cited by 56 · see citing works

Altered redox state of platelet coenzyme Q 10 in Parkinson's disease

Götz, M. E., Gerstner, A., Harth, R., Dirr, A., Janetzky, B., Kuhn, W., Riederer, P., & Gerlach, M. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050003 · Cited by 93 · see citing works

Does High-Dose Coenzyme Q 10 Improve Oxidative Damage and Clinical Outcomes in Parkinson's Disease?

Seet, R. C. S., Lim, E. C. H., Tan, J. J. H., Quek, A. M. L., Chow, A. W. L., Chong, W.-L., Ng, M. P.-E., Ong, C. N., & Halliwell, B. B. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5801 · Cited by 39 · see citing works